| Recruiting | Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hor NCT04553770 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Withdrawn | Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Can NCT03091842 | University of Southern California | N/A |
| Active Not Recruiting | Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa B NCT03414970 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer NCT03345420 | University of Utah | Phase 2 |
| Active Not Recruiting | Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing NCT02927912 | Ohio State University Comprehensive Cancer Center | Phase 2 |
| Completed | Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy NCT03102866 | Ohio State University Comprehensive Cancer Center | N/A |
| Terminated | Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors NCT03284346 | University of Southern California | N/A |
| Terminated | Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage NCT03128619 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Completed | Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer NCT03139435 | Wake Forest University Health Sciences | N/A |
| Completed | Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery NCT03188393 | NRG Oncology | Phase 2 |
| Unknown | Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breas NCT03025139 | Jonsson Comprehensive Cancer Center | N/A |
| Completed | Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hor NCT02760030 | Ohio State University Comprehensive Cancer Center | Phase 2 |
| Active Not Recruiting | Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca NCT02957968 | Virginia Commonwealth University | Phase 2 |
| Completed | S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) NCT02728596 | SWOG Cancer Research Network | N/A |
| Completed | Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative NCT02780401 | University of Washington | Phase 1 |
| Completed | MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Brea NCT02702830 | Wake Forest University Health Sciences | — |
| Completed | Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-I NCT03050463 | Stanford University | — |
| Completed | Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin NCT02677389 | University of Wisconsin, Madison | N/A |
| Completed | Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer Survivors NCT02662335 | Fred Hutchinson Cancer Center | N/A |
| Completed | eHealth Weight Loss Program in African American Breast Cancer Survivors NCT02699983 | Rutgers, The State University of New Jersey | N/A |
| Completed | Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer NCT02432950 | City of Hope Medical Center | N/A |
| Active Not Recruiting | Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy NCT02445391 | ECOG-ACRIN Cancer Research Group | Phase 3 |
| Completed | Attitudes, Beliefs, and Preferences of Older Stage I-III Breast Cancer Survivors Towards Physical Activity NCT02566408 | Case Comprehensive Cancer Center | N/A |
| Completed | Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy NCT02314156 | Northwestern University | Phase 2 |
| Terminated | High-Intensity Interval Training for Stage I-III Breast Cancer Patients NCT02454777 | University of Southern California | N/A |
| Completed | Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering NCT03061175 | Rutgers, The State University of New Jersey | N/A |
| Completed | Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors NCT03198286 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | N/A |
| Active Not Recruiting | Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating NCT02488967 | NRG Oncology | Phase 3 |
| Completed | Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Earl NCT02526498 | Rutgers, The State University of New Jersey | Phase 2 |
| Completed | Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors NCT03039140 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Canc NCT02400060 | Ohio State University Comprehensive Cancer Center | N/A |
| Active Not Recruiting | Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating P NCT02315196 | Rutgers, The State University of New Jersey | Phase 2 |
| Completed | Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer NCT02370277 | University of Southern California | — |
| Withdrawn | KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Ca NCT02168179 | Wake Forest University Health Sciences | N/A |
| Completed | Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors NCT02235051 | City of Hope Medical Center | N/A |
| Completed | Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer NCT02415387 | Ohio State University Comprehensive Cancer Center | EARLY_Phase 1 |
| Completed | Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Pro NCT03233555 | Rutgers, The State University of New Jersey | N/A |
| Active Not Recruiting | Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With NCT01730833 | City of Hope Medical Center | Phase 2 |
| Terminated | Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer NCT01897441 | Albert Einstein College of Medicine | N/A |
| Completed | Broccoli Sprout Extract in Treating Patients With Breast Cancer NCT01753908 | Roswell Park Cancer Institute | EARLY_Phase 1 |
| Completed | Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors NCT01849250 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III NCT01776008 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Brea NCT01750073 | University of Nebraska | Phase 2 |
| Terminated | Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Br NCT02370264 | University of Southern California | N/A |
| Terminated | Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid NCT01409811 | City of Hope Medical Center | N/A |
| Completed | Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Pri NCT01606241 | Mayo Clinic | Phase 1 |
| Active Not Recruiting | Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery NCT01570998 | University of California, San Francisco | N/A |
| Completed | Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors NCT01522820 | Roswell Park Cancer Institute | Phase 1 |
| Active Not Recruiting | Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients Wit NCT01525966 | City of Hope Medical Center | Phase 2 |
| Completed | FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Nega NCT01928186 | University of Washington | N/A |
| Completed | Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Bre NCT01293032 | Virginia Commonwealth University | N/A |
| Terminated | MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer NCT01319539 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Tr NCT01238133 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Sur NCT01106898 | University of Nebraska | Phase 2 |
| Terminated | Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That NCT00450879 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating NCT00066690 | ETOP IBCSG Partners Foundation | Phase 3 |